WuXi AppTec Co., Ltd. (WUXIF)
OTCMKTS · Delayed Price · Currency is USD
7.34
0.00 (0.00%)
Jul 21, 2025, 4:00 PM EDT
WuXi AppTec Revenue
WuXi AppTec had revenue of 9.65B CNY in the quarter ending March 31, 2025, with 20.96% growth. This brings the company's revenue in the last twelve months to 39.59B, up 5.03% year-over-year. In the year 2024, WuXi AppTec had annual revenue of 37.92B, down -1.97%.
Revenue (ttm)
39.59B CNY
Revenue Growth
+5.03%
P/S Ratio
6.03
Revenue / Employee
1.00M CNY
Employees
39,414
Market Cap
32.88B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 37.92B | -760.22M | -1.97% |
Dec 31, 2023 | 38.68B | -676.78M | -1.72% |
Dec 31, 2022 | 39.35B | 16.45B | 71.84% |
Dec 31, 2021 | 22.90B | 6.37B | 38.50% |
Dec 31, 2020 | 16.54B | 3.66B | 28.46% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
WuXi AppTec News
- 25 days ago - WuXi AppTec Nantong Site Receives 2025 Architizer A+Award for Its Unique Blend of Technology and Humanity - PRNewsWire
- 4 weeks ago - WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets - PRNewsWire
- 4 weeks ago - Focus: China pharma projects disrupted by Sino-US tensions - Reuters
- 5 weeks ago - WuXi AppTec Recognized by Extel 2025 Asia Executive Team Rankings with Top Honors - PRNewsWire
- 3 months ago - WuXi AppTec Co., (WUXIF) Ltd. Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - WuXi AppTec Q1 2025 Revenue, Profit Resume Double Digit Growth, Revenue Up 21.0% YoY, Adjusted Non-IFRS Net Profit Up 40.0% YoY; Backlog for Continuing Operations Up 47.1% YoY - PRNewsWire
- 3 months ago - WuXi Group Wrestles With Uncertainty Over Pharma Tariffs - Benzinga
- 4 months ago - WuXi AppTec's Changzhou and Taixing API Sites Successfully Pass FDA Inspections - PRNewsWire